Post-Exposure Therapeutic Efficacy of COX-2 Inhibition against Burkholderia pseudomallei
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Post-Exposure Therapeutic Efficacy of COX-2 Inhibition against Burkholderia pseudomallei
Authors
Keywords
Macrophages, COX-2 inhibitors, Melioidosis, Intracellular pathogens, Mouse models, Respiratory infections, Toll-like receptors, Nitric oxide
Journal
PLoS Neglected Tropical Diseases
Volume 7, Issue 5, Pages e2212
Publisher
Public Library of Science (PLoS)
Online
2013-05-10
DOI
10.1371/journal.pntd.0002212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathogenesis ofBurkholderia pseudomalleiandBurkholderia mallei
- (2013) Joseph C. Larsen et al. MILITARY MEDICINE
- Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4
- (2012) Dawn M. Holt et al. JOURNAL OF IMMUNOTHERAPY
- Melioidosis
- (2012) W. Joost Wiersinga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis
- (2012) Barbara M. Judy et al. PLoS One
- Nasal Acai Polysaccharides Potentiate Innate Immunity to Protect against Pulmonary Francisella tularensis and Burkholderia pseudomallei Infections
- (2012) Jerod A. Skyberg et al. PLoS Pathogens
- Regulation of Immune Responses by Prostaglandin E2
- (2011) P. Kalinski JOURNAL OF IMMUNOLOGY
- Combining Vaccination and Postexposure CpG Therapy Provides Optimal Protection Against Lethal Sepsis in a Biodefense Model of Human Melioidosis
- (2011) Anna Easton et al. JOURNAL OF INFECTIOUS DISEASES
- Inflammasome-dependent Pyroptosis and IL-18 Protect against Burkholderia pseudomallei Lung Infection while IL-1β Is Deleterious
- (2011) Ivonne Ceballos-Olvera et al. PLoS Pathogens
- Evaluation of Surrogate Animal Models of Melioidosis
- (2011) Jonathan Mark Warawa Frontiers in Microbiology
- Modulation of the Arginase Pathway in the Context of Microbial Pathogenesis: A Metabolic Enzyme Moonlighting as an Immune Modulator
- (2010) Priyanka Das et al. PLoS Pathogens
- Immunity to Burkholderia pseudomallei
- (2009) Willem J Wiersinga et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Protection from Pneumonic Infection with Burkholderia Species by Inhalational Immunotherapy
- (2009) A. Goodyear et al. INFECTION AND IMMUNITY
- Differential susceptibility of inbred mouse strains to Burkholderia thailandensis aerosol infection
- (2009) Lisa A. Morici et al. MICROBIAL PATHOGENESIS
- The effect of different Burkholderia pseudomallei isolates of varying levels of virulence on toll-like-receptor expression
- (2009) Marshall Feterl et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Inhalation of Burkholderia thailandensis results in lethal necrotizing pneumonia in mice: a surrogate model for pneumonic melioidosis
- (2009) T. Eoin West et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Activation of Toll-like receptors by Burkholderia pseudomallei
- (2008) T Eoin West et al. BMC IMMUNOLOGY
- Burkholderia thailandensis as a Model System for the Study of the Virulence-Associated Type III Secretion System of Burkholderia pseudomallei
- (2008) A. Haraga et al. INFECTION AND IMMUNITY
- Burkholderia pseudomallei Type III Secretion System Mutants Exhibit Delayed Vacuolar Escape Phenotypes in RAW 264.7 Murine Macrophages
- (2008) M. N. Burtnick et al. INFECTION AND IMMUNITY
- Respiratory Francisella tularensis Live Vaccine Strain Infection Induces Th17 Cells and Prostaglandin E2, Which Inhibits Generation of Gamma Interferon-Positive T Cells
- (2008) M. D. Woolard et al. INFECTION AND IMMUNITY
- Gene-expression profiles in murine melioidosis
- (2008) W. Joost Wiersinga et al. MICROBES AND INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started